EX-99.2 3 ex992to13d10820snse_11032023.htm JOINT FILING AGREEMENT, DATED NOVEMBER 3, 2023

Exhibit 99.2

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, $0.0001 par value per share, of Sensei Biotherapeutics, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Dated: November 3, 2023

  Newtyn Partners, LP
     
  By: Newtyn Management, LLC
Investment Manager
   
  By: /s/ Eugene Dozortsev
    Name: Eugene Dozortsev
    Title: Authorized Signatory

 

 

  Newtyn TE Partners, LP
     
  By: Newtyn Management, LLC
Investment Manager
   
  By: /s/ Eugene Dozortsev
    Name: Eugene Dozortsev
    Title: Authorized Signatory

 

 

  Newtyn Management, LLC
   
  By: /s/ Eugene Dozortsev
    Name: Eugene Dozortsev
    Title: Authorized Signatory

 

 

  Newtyn Capital Partners, LP
     
  By: Ledo Capital, LLC
General Partner
   
  By: /s/ Eugene Dozortsev
    Name: Eugene Dozortsev
    Title: Authorized Signatory

 

 

 

 

  Ledo Capital, LLC
   
  By: /s/ Eugene Dozortsev
    Name: Eugene Dozortsev
    Title: Authorized Signatory

 

 

  /s/ Noah Levy
  Noah Levy